E
Enalees
Development and marketing of lyophilized molecular diagnostic tests for animal healthcare in Europe
About Enalees
Enalees specializes in providing innovative molecular diagnostic tests for veterinary clinics, enabling rapid and accurate detection of infectious diseases in companion animals. The company operates in the animal health market, focusing on point-of-care solutions that allow veterinarians to determine the causative agents of diseases within 40 minutes. This quick turnaround time is crucial for administering timely and effective treatments, thereby improving animal welfare. Enalees serves veterinary professionals who require efficient and reliable diagnostic tools to enhance their service offerings. The business model revolves around the development, production, and distribution of diagnostic test kits, including specialized tests like the COVID-19 test kit for domestic cats. Revenue is generated through the sale of these diagnostic kits to veterinary clinics. Enalees collaborates with other technology and diagnostics companies, such as Bertin Technologies and C4Diagnostics, to enhance its product offerings. The company leverages its expertise in isothermal amplification technology to deliver high-sensitivity and ultra-rapid test results. Key personnel include experienced professionals in animal health and medical biology, ensuring the highest standards in product development and production.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Évry-Courcouronnes, France
- Employees
- 41
- Open positions
- 1
- Dealroom signal
- 76.6/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, Pets, biotech medtech and e-health, Observatoire Deeptech, Hard Tech, Woman Founder, participations bpifrance
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2024 | $17M | $66M | Bpifrance | ↗ |
| GRANTOther financing | Oct 2022 | $550K | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Enalees is 2.3K monthly website visits, up 53.3% over the last three months. Enalees's team grew 2.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
 MolsidWe fight AMR with Faster Diagnostics |
Lyon, France | Operational | 10 | — | — |
 EMOSISDevelops and provides products aim at providing a comprehensive blood tests panel for the bioclinical investigation of thrombosis-induced or thrombosis-complicated diseases |
Illkirch, France | Operational | |||
 HealshapePersonalized, resorbable bioprosthesis for natural breast reconstruction |
Nantes, France | Operational | |||
 OMINIOmini develops biosensing devices for immediate blood tests at the patient bedside |
Paris, France | Operational | |||
 Acs BiotechDeveloping an innovative injectable cartilage repair solution to treat osteoarthritis |
Villeurbanne, France | Operational | |||
 KiroAI helping medical biology |
Paris, France | Operational | |||
 BioSpeediaSpin-off from Institut Pasteur manufacturer of innovative in vitro diagnostics (IVD) rapid diagnostic tests |
Paris, France | Operational | |||
 C4DiagnosticsFast detection and count of microorganisms |
Marseille, France | Closed |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Other known investors2 additional known investors
Auriga Partners (Paris)
Business Angels Des Grandes Ecoles
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Enalees on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enalees’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.